Synapse - Carol Portlock

Search Within

Carol Portlock

Results (206)

PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin

Meeting Abstract

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Haematologica (2016)

Fulltext@MSK | Save

Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma

Journal Article

Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
Blood (2016)

Fulltext@MSK | Save

Prospective study of 3′-deoxy-3′-(18)F-fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma

Journal Article

Schoder, H.; Zelenetz, A. D.; Hamlin, P.; Gavane, S.; Horwitz, S.; Matasar, M.; Moskowitz, A.; Noy, A.; Palomba, L.; Portlock, C.; more...
Journal of Nuclear Medicine (2016)

Fulltext@MSK | Save

Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adults

Journal Article

Portlock, C. S.
Clinical Oncology in Adolescents and Young Adults (2015)

Fulltext@MSK | Save

Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma

Meeting Abstract

Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
Blood (2015)

Fulltext@MSK | Save

A prospective study of allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Perales, M. A.; Cho, C.; Eaton, A.; Moskowitz, A. J.; Nguyen, V.; Gonzales-Dadiz, A. M. R.; Devlin, S.; Giralt, S. A.; Jakubowski, A. A.; Matasar, M. J.; more...
Blood (2015)

Fulltext@MSK | Save

Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay

Meeting Abstract

Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
Blood (2015)

Fulltext@MSK | Save

Long-term outcome of 490 patients with early-stage extra-nodal marginal zone lymphoma

Meeting Abstract

Yahalom, J.; Teckie, S.; Qi, S.; Hsu, M.; Lovie, S.; Chelius, M.; Noy, A.; Portlock, C.
Haematologica (2015)

Fulltext@MSK | Save

Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial

Meeting Abstract

Owens, C. N.; Iannotta, A.; Gerecitano, J. F.; Matasar, M. J.; Noy, A.; Moskowitz, C. H.; Drullinsky, P.; Palomba, M. L.; Straus, D. J.; Horwitz, S. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy

Journal Article

Gandikota, N.; Hartridge-Lambert, S.; Migliacci, J. C.; Yahalom, J.; Portlock, C. S.; Schöder, H.
Cancer (2015)

Fulltext@MSK | Save